Cost-effectiveness analyses have not been conducted on the DAPA-HF trial as of yet, but in healthcare systems in which dapagliflozin is not particularly expensive, results are likely to be favorable, said John McMurray, MD, FRCP, FESC, professor of medical cardiology in the Institute of Cardiovascular and Medical Sciences at the University of Glasgow.
Cost-effectiveness analyses have not been conducted on the DAPA-HF trial as of yet, but in healthcare systems in which dapagliflozin is not particularly expensive, results are likely to be favorable, said John McMurray, MD, FRCP, FESC, professor of medical cardiology in the Institute of Cardiovascular and Medical Sciences at the University of Glasgow.
Transcript
Is dapagliflozin cost-effective relative to other therapies to prevent worsening of heart failure? If so, can you discuss?
We've not published a formal cost-effectiveness analysis of the DAPA-HF trial, but cost-effectiveness studies in heart failure are not very complicated. So, largely, it's about the difference between the cost of the therapy and monitoring the therapy. The cost offsets by reducing the expense of complications of heart failure, and of course, the biggest 1 of those is heart failure hospitalization—that accounts for about 70% of healthcare expenditure in heart failure. It's not devices, it’s not heart transplants–it’s heart failure hospitalization, that's the big ticket economic item. We reduce the risk of heart failure hospitalization by 30%. So, if you live in a healthcare system where dapagliflozin is not a particularly expensive drug, like in my healthcare system, then the balance between cost, cost offset, and overall cost-effectiveness is likely to be favorable.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen